ECSP10010576A - Formulaciones orales e inyectables de compuestos de tetraciclina - Google Patents

Formulaciones orales e inyectables de compuestos de tetraciclina

Info

Publication number
ECSP10010576A
ECSP10010576A EC2010010576A ECSP10010576A ECSP10010576A EC SP10010576 A ECSP10010576 A EC SP10010576A EC 2010010576 A EC2010010576 A EC 2010010576A EC SP10010576 A ECSP10010576 A EC SP10010576A EC SP10010576 A ECSP10010576 A EC SP10010576A
Authority
EC
Ecuador
Prior art keywords
oral
tetracicline
compounds
injectable formulations
minocycline
Prior art date
Application number
EC2010010576A
Other languages
English (en)
Inventor
Sean Johnston
Original Assignee
Paratek Pharm Innc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41114256&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP10010576(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Paratek Pharm Innc filed Critical Paratek Pharm Innc
Publication of ECSP10010576A publication Critical patent/ECSP10010576A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una formulacion oral de 9-[(2,2-dimetil propil amino)-metil]-minociclina o una sal de la misma en forma de tableta.
EC2010010576A 2008-03-28 2010-10-27 Formulaciones orales e inyectables de compuestos de tetraciclina ECSP10010576A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4039808P 2008-03-28 2008-03-28

Publications (1)

Publication Number Publication Date
ECSP10010576A true ECSP10010576A (es) 2010-12-30

Family

ID=41114256

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010576A ECSP10010576A (es) 2008-03-28 2010-10-27 Formulaciones orales e inyectables de compuestos de tetraciclina

Country Status (31)

Country Link
US (2) US9314475B2 (es)
EP (3) EP3348258B1 (es)
JP (7) JP2011515473A (es)
KR (3) KR101893740B1 (es)
CN (1) CN102046177B (es)
AU (1) AU2009229174A1 (es)
BR (2) BR122020011180B8 (es)
CA (2) CA2719751C (es)
CL (1) CL2010000281A1 (es)
CO (1) CO6300935A2 (es)
CY (2) CY1120240T1 (es)
DK (2) DK2271348T3 (es)
EC (1) ECSP10010576A (es)
ES (2) ES2674708T3 (es)
HK (1) HK1257928A1 (es)
HR (2) HRP20180836T1 (es)
HU (2) HUE038257T2 (es)
IL (1) IL208440A0 (es)
LT (2) LT2271348T (es)
MA (1) MA32275B1 (es)
MX (1) MX2010010585A (es)
NO (1) NO2271348T3 (es)
NZ (1) NZ588428A (es)
PL (2) PL2271348T3 (es)
PT (2) PT2271348T (es)
RU (1) RU2010144130A (es)
SI (2) SI3348258T1 (es)
TR (1) TR201806893T4 (es)
UA (2) UA109627C2 (es)
WO (1) WO2009120389A1 (es)
ZA (1) ZA201007013B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010009693A (es) 2008-03-05 2010-12-20 Paratek Pharm Innc Compuestos de monociclina y metodos de uso de la misma.
TWI680117B (zh) 2008-05-23 2019-12-21 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
BR112012028524B1 (pt) 2010-05-12 2022-03-15 Rempex Pharmaceuticals, Inc Composições farmacêuticas e respectivos usos, métodos de preparação e kit
SG11201809561WA (en) * 2016-05-02 2018-11-29 Paratek Pharm Innc 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (uti) treatment
US10166912B2 (en) 2016-08-19 2019-01-01 Sl Corporation Automotive LED driving apparatus
US10383884B2 (en) 2016-11-01 2019-08-20 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
CN113164456A (zh) * 2018-09-04 2021-07-23 帕拉特克药品公司 使用四环素化合物治疗分枝杆菌感染的方法
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US2712517A (en) * 1954-03-03 1955-07-05 Bristol Lab Inc Production of tetracycline and substituted tetracyclines
US3019173A (en) * 1956-06-04 1962-01-30 American Cyanamid Co Method for preparing tetracycline
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US3005023A (en) * 1957-04-05 1961-10-17 American Cyanamid Co Production of tetracycline
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2886595A (en) * 1958-09-30 1959-05-12 Bristol Lab Inc Tetracycline recovery
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3019260A (en) * 1959-05-13 1962-01-30 American Cyanamid Co Process for the catalytic reduction of 6-hydroxy hydronaphthacenes
FR1430859A (es) * 1960-05-23 1966-05-25
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3301899A (en) * 1963-11-27 1967-01-31 Bristol Myers Co Purification of tetracycline
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
NL6607516A (es) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
DE122006000058I1 (de) 1991-10-04 2007-01-18 Wyeth Corp 7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US6465431B1 (en) * 1999-11-17 2002-10-15 Boston Life Sciences, Inc. Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
CN1268888A (zh) 1997-08-29 2000-10-04 Dsm公司 不含赋形剂的颗粒
KR100252699B1 (ko) * 1998-03-17 2000-12-01 강재헌 치주염 치료용 미노사이클린 조성물
WO2000028983A1 (en) 1998-11-18 2000-05-25 Collagenex Pharmaceuticals, Inc. Novel 4-dedimethy laminotetra cycline derivatives
US6448323B1 (en) 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
EP1254666A4 (en) * 1999-12-28 2004-12-22 Chugai Pharmaceutical Co Ltd STABLE ANTIBODY COMPOSITIONS AND INJECTION FORMULATIONS
EP3461808A1 (en) * 2000-07-07 2019-04-03 Trustees of Tufts College 9-substituted minocycline compounds
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
US6683068B2 (en) 2001-03-13 2004-01-27 Paratek Pharmaceuticals, Inc. 7, 9-substituted tetracycline compounds
US7045507B2 (en) * 2001-03-14 2006-05-16 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
NZ529308A (en) 2001-04-05 2005-03-24 Collagenex Pharm Inc Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US20040063674A1 (en) * 2001-07-13 2004-04-01 Levy Stuart B. Tetracycline compounds having target therapeutic activities
EA200802365A1 (ru) * 2002-03-08 2009-08-28 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
CN1390550A (zh) * 2002-07-25 2003-01-15 于航 盐酸米诺环素冻干粉针剂及其制备方法
EP2277504A1 (en) * 2002-10-24 2011-01-26 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
AU2003287217B2 (en) * 2002-10-24 2010-03-04 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate RNA
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
WO2004064728A2 (en) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Use of specific tetracycline compounds in therapy
EP1596825A2 (en) * 2003-02-03 2005-11-23 Neopharm, Inc. Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
WO2004078111A2 (en) * 2003-03-06 2004-09-16 Ranbaxy Laboratories Limited Extended release minocycline compositions and processes for their preparation
WO2004091513A2 (en) * 2003-04-10 2004-10-28 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
WO2005009944A1 (en) * 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
AU2004259659B2 (en) * 2003-07-09 2011-11-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2553510C (en) * 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
CA2602089C (en) * 2005-03-14 2013-04-30 Wyeth Tigecycline compositions and methods of preparation
JP2009524675A (ja) * 2006-01-24 2009-07-02 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリンの経口バイオアベイラビリティーを増加する方法
US20090246276A1 (en) * 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
MX2010009693A (es) * 2008-03-05 2010-12-20 Paratek Pharm Innc Compuestos de monociclina y metodos de uso de la misma.

Also Published As

Publication number Publication date
JP2016145260A (ja) 2016-08-12
CA2719751C (en) 2018-01-02
NZ588428A (en) 2012-08-31
KR101893740B1 (ko) 2018-08-30
KR101835574B1 (ko) 2018-03-08
CY1123382T1 (el) 2021-12-31
RU2010144130A (ru) 2012-05-10
EP3789030A1 (en) 2021-03-10
HUE052201T2 (hu) 2021-04-28
HRP20201883T1 (hr) 2021-01-22
DK2271348T3 (en) 2018-06-14
AU2009229174A1 (en) 2009-10-01
CO6300935A2 (es) 2011-07-21
HRP20180836T1 (hr) 2018-07-27
CN102046177A (zh) 2011-05-04
BR122020011180B8 (pt) 2021-07-27
JP6412521B2 (ja) 2018-10-24
SI2271348T1 (en) 2018-08-31
ES2674708T3 (es) 2018-07-03
JP2019196408A (ja) 2019-11-14
NO2271348T3 (es) 2018-08-25
TR201806893T4 (tr) 2018-06-21
BRPI0909211A2 (pt) 2016-11-29
DK3348258T3 (da) 2020-12-07
WO2009120389A8 (en) 2009-12-30
JP2021167355A (ja) 2021-10-21
CA2984301C (en) 2020-10-27
JP2011515473A (ja) 2011-05-19
HK1257928A1 (zh) 2019-11-01
MA32275B1 (fr) 2011-05-02
PT2271348T (pt) 2018-04-16
JP2014221820A (ja) 2014-11-27
LT2271348T (lt) 2018-06-25
JP2023144043A (ja) 2023-10-06
EP2271348B1 (en) 2018-03-28
JP2018203778A (ja) 2018-12-27
CY1120240T1 (el) 2019-07-10
JP6577645B2 (ja) 2019-09-18
CA2719751A1 (en) 2009-10-01
US20100056638A1 (en) 2010-03-04
CA2984301A1 (en) 2009-10-01
PL2271348T3 (pl) 2018-08-31
PL3348258T3 (pl) 2021-03-08
KR101746228B1 (ko) 2017-06-12
PT3348258T (pt) 2020-11-25
CN102046177B (zh) 2012-12-19
MX2010010585A (es) 2010-11-09
LT3348258T (lt) 2020-12-10
BR122020011180B1 (pt) 2021-03-23
EP2271348A1 (en) 2011-01-12
BRPI0909211B8 (pt) 2021-05-25
ES2836448T3 (es) 2021-06-25
CL2010000281A1 (es) 2012-03-30
UA122762C2 (uk) 2021-01-06
JP5940119B2 (ja) 2016-06-29
WO2009120389A1 (en) 2009-10-01
HUE038257T2 (hu) 2018-10-29
KR20160105532A (ko) 2016-09-06
SI3348258T1 (sl) 2020-12-31
US20160279151A1 (en) 2016-09-29
BRPI0909211B1 (pt) 2020-08-25
US9314475B2 (en) 2016-04-19
KR20180026799A (ko) 2018-03-13
EP3348258A1 (en) 2018-07-18
EP3348258B1 (en) 2020-09-09
KR20110008057A (ko) 2011-01-25
IL208440A0 (en) 2010-12-30
EP2271348A4 (en) 2011-05-25
UA109627C2 (uk) 2015-09-25
ZA201007013B (en) 2013-11-27

Similar Documents

Publication Publication Date Title
FR21C1040I1 (fr) Formulations d'anticorps anti-cd20
ECSP10010576A (es) Formulaciones orales e inyectables de compuestos de tetraciclina
LTPA2018014I1 (lt) Farmacinė kompozicija 514
CY1117615T1 (el) Ενωσεις θειαζολης σουλφοναμιδης και οξαζολης
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
ECSP12012208A (es) Formulaciones orales y sales lipofílicas de metilnaltrexona
BRPI0811110A2 (pt) Formulação de nicotina oral tamponada com aminoácido
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BR112015014478A2 (pt) complexo de haleto de aminoácido e zinco com cisteína
DK2328601T3 (da) Linaclotid-holdige formuleringer til oral indgivelse
NO20075628L (no) Farmasøytiske formuleringer
BRPI0716365A2 (pt) "artigo odontolàgico"
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
CY1121421T1 (el) Φαρμακοτεχνικες μορφες
CL2008000896A1 (es) Composicion que mantiene el cuidado bucal periodico que comprende un aminoacido basico; uso en el tratamiento terapeutico de la superficie bucal.
CL2012003012A1 (es) Composicion farmaceutica oral de liberacion prolongada que comprenden a) al menos un material de liberacion prolongada y b) hidromorfona o una sal y naloxona o una sal en una relacion 2:1 a 1:3; metodo de preparacion.
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
RS54238B1 (en) ORAL FILM FORMULATIONS CONTAINING DAPOXETINE AND TADALAFIL
ECSP11011286A (es) Formulaciones orales sólidas de una pirido-pirimidinona
SV2009003287A (es) Agentes para combatir parasitos en animales
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
BR122016006880B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
ITMI20051273A1 (it) Composizioni in forma di lipogel per uso cosmetico detergente e farmaceutico
SM200500011A (it) Una composizione farmaceutica antimicobatterica